Literature DB >> 418070

Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin.

G J Roth, C J Siok.   

Abstract

Aspirin (acetylsalicylic acid) inhibits prostaglandin synthesis by acetylating an active site portion of the enzyme, prostaglandin synthetase. In the current study, the site of acetylation has been demonstrated to be a seryl residue at the NH2 terminus of the enzyme. Purified [3H]acetyl enzyme was prepared from seminal vesicle homogenates treated with [acetyl-3H]aspirin. The [3H]acetate to protein bond was stable to hydroxylamine, indicating an N-acetyl linkage. The [3H]acetyl enzyme was fragmented sequentially with cyanogen bromide, trypsin, and pronase. The 3H material isolated from the pronase digest was identified as N-acetylserine. This finding indicates that the oxygenase portion of prostaglandin synthetase has an NH2-terminal serine which is involved in enzymatic activity and is susceptible to acetylation by aspirin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 418070

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Aspirin resistance and diabetes mellitus.

Authors:  R Ajjan; R F Storey; P J Grant
Journal:  Diabetologia       Date:  2008-03       Impact factor: 10.122

2.  [Not Available].

Authors:  E Hackenthal
Journal:  Schmerz       Date:  1990-09       Impact factor: 1.107

3.  Purification and characterization of sheep platelet cyclo-oxygenase. Acetylation by aspirin prevents haemin binding to the enzyme.

Authors:  R Boopathy; A S Balasubramanian
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

Review 4.  Atherosclerosis: the eicosanoid connection.

Authors:  A N Makheja
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

5.  Current management of juvenile arthritis.

Authors:  J Chaitow
Journal:  Indian J Pediatr       Date:  1986 Sep-Oct       Impact factor: 1.967

Review 6.  Aspirin for myocardial infarction. Clinical pharmacokinetic considerations.

Authors:  F Bochner; J V Lloyd
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

7.  Release of prostacyclin from the human pulmonary vascular bed in response to cholinergic stimulation.

Authors:  R Brandt; A Dembińska-Kieć; R Korbut; R J Gryglewski; J Nowak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

8.  Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.

Authors:  L A Spry; T V Zenser; S M Cohen; B B Davis
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

9.  Differential effect of acetylsalicylic acid and dipyrone on prostaglandin production in human fibroblast cultures.

Authors:  C Lüthy; M Multhaupt; O Oetliker; M Perisic
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

10.  Pseudo-esterase activity of human albumin: slow turnover on tyrosine 411 and stable acetylation of 82 residues including 59 lysines.

Authors:  Oksana Lockridge; Weihua Xue; Andrea Gaydess; Hasmik Grigoryan; Shi-Jian Ding; Lawrence M Schopfer; Steven H Hinrichs; Patrick Masson
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.